ly3009120 and osimertinib
ly3009120 has been researched along with osimertinib* in 1 studies
*osimertinib: an EGFR tyrosine kinase inhibitor [MeSH]
*osimertinib: an EGFR tyrosine kinase inhibitor [MeSH]
Other Studies
1 other study(ies) available for ly3009120 and osimertinib
Article | Year |
---|---|
The combination of osimertinib with Raf inhibitor overcomes osimertinib resistance induced by KRAS amplification in EGFR-mutated lung cancer cells.
Topics: Aniline Compounds; Animals; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Lung Neoplasms; Mice; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras) | 2023 |